BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 16413676)

  • 1. Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells.
    Yang W; Monroe J; Zhang Y; George D; Bremer E; Li H
    Cancer Lett; 2006 Nov; 243(2):217-27. PubMed ID: 16413676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasome inhibitors cause induction of heat shock proteins and trehalose, which together confer thermotolerance in Saccharomyces cerevisiae.
    Lee DH; Goldberg AL
    Mol Cell Biol; 1998 Jan; 18(1):30-8. PubMed ID: 9418850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasomal inhibition triggers viral oncoprotein degradation via autophagy-lysosomal pathway.
    Gain C; Malik S; Bhattacharjee S; Ghosh A; Robertson ES; Das BB; Saha A
    PLoS Pathog; 2020 Feb; 16(2):e1008105. PubMed ID: 32092124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A system-based comparison of gene expression reveals alterations in oxidative stress, disruption of ubiquitin-proteasome system and altered cell cycle regulation after exposure to cadmium and methylmercury in mouse embryonic fibroblast.
    Yu X; Robinson JF; Sidhu JS; Hong S; Faustman EM
    Toxicol Sci; 2010 Apr; 114(2):356-77. PubMed ID: 20061341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome inhibitors induce apoptosis by superoxide anion generation via NADPH oxidase 5 in human neuroblastoma SH-SY5Y cells.
    Yamamuro-Tanabe A; Oshima Y; Iyama T; Ishimaru Y; Yoshioka Y
    J Pharmacol Sci; 2024 Jun; 155(2):52-62. PubMed ID: 38677786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activation sequence of cellular protein handling systems after proteasomal inhibition in dopaminergic cells.
    Xiong R; Siegel D; Ross D
    Chem Biol Interact; 2013 Jul; 204(2):116-24. PubMed ID: 23684743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteasome inhibitors modulate anticancer and anti-proliferative properties via NF-kB signaling, and ubiquitin-proteasome pathways in cancer cell lines of different organs.
    Qureshi AA; Zuvanich EG; Khan DA; Mushtaq S; Silswal N; Qureshi N
    Lipids Health Dis; 2018 Apr; 17(1):62. PubMed ID: 29606130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of autophagy promotes cell apoptosis induced by the proteasome inhibitor MG-132 in human esophageal squamous cell carcinoma EC9706 cells.
    Liu D; Gao M; Yang Y; Qi YU; Wu K; Zhao S
    Oncol Lett; 2015 May; 9(5):2278-2282. PubMed ID: 26137056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis of MG132-treated germinating pollen reveals expression signatures associated with proteasome inhibition.
    Vannini C; Bracale M; Crinelli R; Marconi V; Campomenosi P; Marsoni M; Scoccianti V
    PLoS One; 2014; 9(9):e108811. PubMed ID: 25265451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynein function and protein clearance changes in tumor cells induced by a Kunitz-type molecule, Amblyomin-X.
    Pacheco MT; Berra CM; Morais KL; Sciani JM; Branco VG; Bosch RV; Chudzinski-Tavassi AM
    PLoS One; 2014; 9(12):e111907. PubMed ID: 25479096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome Inhibition Reprograms Chromatin Landscape in Breast Cancer.
    Kinyamu HK; Bennett BD; Ward JM; Archer TK
    Cancer Res Commun; 2024 Apr; 4(4):1082-1099. PubMed ID: 38625038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unlocking the Potential of Kinase Targets in Cancer: Insights from CancerOmicsNet, an AI-Driven Approach to Drug Response Prediction in Cancer.
    Singha M; Pu L; Srivastava G; Ni X; Stanfield BA; Uche IK; Rider PJF; Kousoulas KG; Ramanujam J; Brylinski M
    Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy: a potential key contributor to the therapeutic action of mesenchymal stem cells.
    Ceccariglia S; Cargnoni A; Silini AR; Parolini O
    Autophagy; 2020 Jan; 16(1):28-37. PubMed ID: 31185790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome inhibitors, including curcumin, improve pancreatic β-cell function and insulin sensitivity in diabetic mice.
    Weisberg S; Leibel R; Tortoriello DV
    Nutr Diabetes; 2016 Apr; 6(4):e205. PubMed ID: 27110686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ubiquitin-Proteasome System: Potential Therapeutic Targets for Alzheimer's Disease and Spinal Cord Injury.
    Gong B; Radulovic M; Figueiredo-Pereira ME; Cardozo C
    Front Mol Neurosci; 2016; 9():4. PubMed ID: 26858599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Huwe1 interacts with Gadd45b under oxygen-glucose deprivation and reperfusion injury in primary Rat cortical neuronal cells.
    He GQ; Xu WM; Li JF; Li SS; Liu B; Tan XD; Li CQ
    Mol Brain; 2015 Dec; 8():88. PubMed ID: 26698301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymer micelle formulations of proteasome inhibitor carfilzomib for improved metabolic stability and anticancer efficacy in human multiple myeloma and lung cancer cell lines.
    Ao L; Reichel D; Hu D; Jeong H; Kim KB; Bae Y; Lee W
    J Pharmacol Exp Ther; 2015 Nov; 355(2):168-73. PubMed ID: 26311812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy protein p62/SQSTM1 is involved in HAMLET-induced cell death by modulating apotosis in U87MG cells.
    Zhang YB; Gong JL; Xing TY; Zheng SP; Ding W
    Cell Death Dis; 2013 Mar; 4(3):e550. PubMed ID: 23519119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling drug-induced cell death pathways in the zebrafish lateral line.
    Coffin AB; Williamson KL; Mamiya A; Raible DW; Rubel EW
    Apoptosis; 2013 Apr; 18(4):393-408. PubMed ID: 23413197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic targeting of cancer cell cycle using proteasome inhibitors.
    Rastogi N; Mishra DP
    Cell Div; 2012 Dec; 7(1):26. PubMed ID: 23268747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.